Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CODEx: Step Test Sensitivity in COPD
NCT01655199Phase 3Unknown
- Sponsor
- Université Laval
- Start
- Sep 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ipratropium bromide, salbutamol in chronic obstructive pulmonary disease (COPD), sponsored by Université Laval. Status: unknown.
02
Drugs
ipratropium bromidesalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01655199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655199.